Compile Data Set for Download or QSAR
Report error Found 73 Enz. Inhib. hit(s) with all data for entry = 12837
TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732398(US20250115563, Compound 113)
Affinity DataEC50: <10nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732427(US20250115563, Compound 142)
Affinity DataEC50: <10nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732394(US20250115563, Compound 109)
Affinity DataEC50: <10nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732457(US20250115563, Compound 172)
Affinity DataEC50: <10nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732424(US20250115563, Compound 139)
Affinity DataEC50: <10nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732456(US20250115563, Compound 171)
Affinity DataEC50: <10nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732455(US20250115563, Compound 170)
Affinity DataEC50: <10nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732400(US20250115563, Compound 115)
Affinity DataEC50: <10nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732413(US20250115563, Compound 128)
Affinity DataEC50: <10nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732411(US20250115563, Compound 126)
Affinity DataEC50: <10nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732443(US20250115563, Compound 158)
Affinity DataEC50: <10nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732390(US20250115563, Compound 105)
Affinity DataEC50: <10nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732453(US20250115563, Compound 168)
Affinity DataEC50: <10nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732386(US20250115563, Compound 101)
Affinity DataEC50: <10nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732418(US20250115563, Compound 133)
Affinity DataEC50: <10nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732417(US20250115563, Compound 132)
Affinity DataEC50: <10nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732416(US20250115563, Compound 131)
Affinity DataEC50: <10nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732430(US20250115563, Compound 145)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732396(US20250115563, Compound 111)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732395(US20250115563, Compound 110)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732426(US20250115563, Compound 141)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732425(US20250115563, Compound 140)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732423(US20250115563, Compound 138)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732406(US20250115563, Compound 121)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732405(US20250115563, Compound 120)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732402(US20250115563, Compound 117)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732401(US20250115563, Compound 116)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732433(US20250115563, Compound 148)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732414(US20250115563, Compound 129)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732446(US20250115563, Compound 161)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732445(US20250115563, Compound 160)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732444(US20250115563, Compound 159)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732408(US20250115563, Compound 123)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732407(US20250115563, Compound 122)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732421(US20250115563, Compound 136)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732388(US20250115563, Compound 103)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732420(US20250115563, Compound 135)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732452(US20250115563, Compound 167)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732385(US20250115563, Compound 100)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732415(US20250115563, Compound 130)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732447(US20250115563, Compound 162)
Affinity DataEC50:  20nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732428(US20250115563, Compound 143)
Affinity DataEC50:  65nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732393(US20250115563, Compound 108)
Affinity DataEC50:  65nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732392(US20250115563, Compound 107)
Affinity DataEC50:  65nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732391(US20250115563, Compound 106)
Affinity DataEC50:  65nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732404(US20250115563, Compound 119)
Affinity DataEC50:  65nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732403(US20250115563, Compound 118)
Affinity DataEC50:  65nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732399(US20250115563, Compound 114)
Affinity DataEC50:  65nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732431(US20250115563, Compound 146)
Affinity DataEC50:  65nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetTranscription factor 4(Human)
Calico Life Sciences

US Patent
LigandPNGBDBM732412(US20250115563, Compound 127)
Affinity DataEC50:  65nMAssay Description:In order to test exemplary compounds of the invention in a cellular context, a stable VWMD cell line was first constructed. The ATF4 reporter was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

Displayed 1 to 50 (of 73 total ) | Next | Last >>
Jump to: